Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy

AIMS: Tafamidis improves prognosis in patients with transthyretin amyloid cardiomyopathy (ATTR‐CM). However, real‐world data on the therapeutic effect of tafamidis are lacking. This study aimed to evaluate the clinical course, outcomes, and effectivity monitoring of the therapeutic effect of tafamid...

Descripción completa

Detalles Bibliográficos
Autores principales: Takashio, Seiji, Morioka, Mami, Ishii, Masanobu, Morikawa, Kei, Hirakawa, Kyoko, Hanatani, Shinsuke, Oike, Fumi, Usuku, Hiroki, Kidoh, Masafumi, Oda, Seitaro, Yamamoto, Eiichiro, Matsushita, Kenichi, Ueda, Mitsuharu, Tsujita, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375127/
https://www.ncbi.nlm.nih.gov/pubmed/37073415
http://dx.doi.org/10.1002/ehf2.14380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375127/
https://www.ncbi.nlm.nih.gov/pubmed/37073415
http://dx.doi.org/10.1002/ehf2.14380

Ejemplares similares